NCT05540626View on ClinicalTrials.gov

RWE Study Utilizing the Cala Trio Device in Patients With Essential Tremor

NACompletedINTERVENTIONAL
Enrollment

276

Participants

Timeline

Start Date

April 8, 2021

Primary Completion Date

March 1, 2024

Study Completion Date

March 1, 2024

Conditions
Essential Tremor
Interventions
DEVICE

Cala Trio

transcutaneous afferent patterned stimulation (TAPS)

Trial Locations (1)

94404

Cala Health, San Mateo

Sponsors

Lead Sponsor

Cala Health, Inc.
All Listed Sponsors
collaborator

CVS Healthspire Life Sciences Solutions

UNKNOWN

lead

Cala Health, Inc.

INDUSTRY